H. Loeser

发表

MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.

M. von Brandenstein, Jency J. Pandarakalam, Lukas Kroon, 2012, The American journal of pathology.

The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma

T. Zander, A. Quaas, H. Loeser, 2019, Oncoimmunology.

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma

T. Zander, A. Quaas, H. Loeser, 2020, Journal of immunology research.

Potential complications of transcatheter aortic valve implantation (TAVI)-an autopsy perspective.

H. Loeser, J. Fries, R. Buettner, 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma1

T. Zander, A. Quaas, A. Hillmer, 2018, Translational oncology.

Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus

T. Zander, A. Quaas, A. Hölscher, 2018, Journal of Cancer Research and Clinical Oncology.

ET-1 Induced Downregulation of MRP2 via miRNA 133a - A Marker for Tubular Nephrotoxicity?

M. von Brandenstein, H. Loeser, J. Fries, 2015, American Journal of Nephrology.

Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma

T. Zander, A. Quaas, H. Loeser, 2020, Journal of Cancer Research and Clinical Oncology.

Acute exercise induces natural killer cell mobilization but not infiltration into prostate cancer tissue in humans

H. Loeser, S. Theurich, C. Watzl, 2022, medRxiv.

Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal Cancer

T. Zander, A. Quaas, H. Loeser, 2022, Annals of Surgical Oncology.

High protein and mRNA expression levels of TUBB3 (class III ß-tubulin) are associated with aggressive tumor features in esophageal adenocarcinomas

T. Zander, A. Quaas, A. Hölscher, 2017, Oncotarget.

Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies

T. Zander, A. Quaas, H. Loeser, 2020, Oncology letters.

Distribution of tumor-infiltrating-T-lymphocytes and possible tumor-escape mechanisms avoiding immune cell attack in locally advanced adenocarcinomas of the esophagus

T. Zander, A. Hillmer, H. Loeser, 2021, Clinical and Translational Oncology.

Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas

T. Zander, A. Quaas, A. Hillmer, 2020, BMC Cancer.

PIK3CA and KRAS Amplification in Esophageal Adenocarcinoma and their Impact on the Inflammatory Tumor Microenvironment and Prognosis

T. Zander, A. Quaas, A. Hillmer, 2019, Translational oncology.

Optimized PD-L1 scoring of gastric cancer

T. Zander, A. Quaas, H. Loeser, 2021, Gastric Cancer.

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

T. Zander, A. Quaas, A. Hölscher, 2019, BMC Cancer.

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma

T. Zander, A. Quaas, A. Hölscher, 2019, BMC Cancer.

Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations: Update on Genotype-Phenotype Correlation and Validation of a High-Resolution Melting Assay for Mutational Testing

E. Wardelmann, P. Hohenberger, H. Loeser, 2013, The American journal of surgical pathology.

Y Chromosome Loss Is a Frequent Event in Barrett’s Adenocarcinoma and Associated with Poor Outcome

T. Zander, A. Quaas, A. Hillmer, 2020, Zeitschrift für Gastroenterologie.

Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma

T. Zander, A. Quaas, A. Hillmer, 2020, BMC Cancer.

Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies

T. Zander, A. Quaas, H. Loeser, 2020, Therapeutic advances in medical oncology.

Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence.

K. Hekmat, A. Quaas, J. Wolf, 2020, Lung cancer.

Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma

T. Zander, A. Quaas, H. Loeser, 2020, Cancer Immunology, Immunotherapy.

Somatic BRCA1-associated protein 1 (BAP1) loss is an early and rare event in esophageal adenocarcinoma.

T. Zander, A. Quaas, H. Loeser, 2017, Molecular and clinical oncology.

Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma

T. Zander, A. Quaas, A. Hillmer, 2020, BMC Cancer.

Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center

T. Zander, A. Quaas, A. Hillmer, 2021, Frontiers in Oncology.

In Glomerular Disease, Urinary microRNA15a is A Biomarker for Inflammatory Signaling Mediated by Protein and Endothelin-1

C. Richter, H. Loeser, R. Buettner, 2018 .

Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival

Matthias Scholz, T. Zander, A. Quaas, 2020, Scientific Reports.

Varioliform gastritis: an unusual endoscopic finding

H. Loeser, T. Goeser, P. Kasper, 2018, Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology.

Copy-number variation and protein expression of DOT1L in pancreatic adenocarcinoma as a potential drug target

T. Zander, A. Quaas, H. Loeser, 2017, Molecular and clinical oncology.

Dickkopf-2 (DKK2) as Context Dependent Factor in Patients with Esophageal Adenocarcinoma

T. Zander, A. Quaas, H. Loeser, 2020, Cancers.